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To study the mechanism of tea polyphenols (TP)-induced apoptosis of breast cancer cells. Proliferation of
MCF-7 and SK-BR-3 cells was evaluated by MTT assays. Cellular ultrastructure was examined by electron
microscopy. Apoptosis was detected by TUNEL. PCNA Cyclin D1 Cyclin E and Survivin expression was
measured byWestern blot. Cell proliferation was significantly inhibited by TP. Spindle and round cells were
loosely distributed with increased particles after TP treatment. Increased cell size, frequent nuclear atypia
and a collapse of apoptosis were observed. The nucleus was pushed towards one side, while the cytoplasm
was rich in free ribosome. The membrane of mitochondria was thickening, and the cell apoptotic body was
observed. TP treated cells experienced significantly enhanced apoptosis compared with 5-Fu treated or
control groups. The expression of survivin was downregulated by TP. To conclude, TP can inhibit cell
growth and induce apoptosis through downregulating the expression of survivin in breast cancer.
P
hytochemicals has been introduced to support the immune system or fight against diseases1. Green tea and
its constituents are important components of diet-based strategies to prevent various malignancies1. The
anti-carcinogenic and anti-mutagenic activities of green tea may provide protection and reduce cancer
prevalence1. The pharmacological features of green tea are derived from polyphenols including epigallocatechin,
epigallocatechin-3-gallate, epicatechin, and epicatechin-3-gallate1. Green tea and its components effectively
mitigate cellular damages from oxidative stress1. A large number of studies have shown that tea polyphenols
(TP) can enhance human immunity so that protect from a variety of diseases such as cardiovascular events and
cancer, owing to its anti-oxidant, anti-radiation, antibacterial, antiviral, anti-diabetic, and anti-aging functions2–4.
Accumulating evidence indicates that TP can scavenge free radicals, induce detoxification enzymes, and regulate
immune function5,6. TP can induce apoptosis of cancer cells through caspases cascade and p535,7. Further
investigation on TP-induced apoptosis of tumor cells may provide a theoretical basis for the development of
novel antitumor drugs.
Breast cancer is the most common malignancy in women with increased incidence worldwide. Although anti-
tumor activity of TP in breast cancer has been indicated, its molecular mechanism is yet to be clarified8. Poor
prognosis of breast cancer is partially attributed to multiple-drug resistance and anti-apoptosis of cancer cells9.
Survivin, an inhibitor of apoptosis is highly expressed in most cancers and closely related to multiple-drug
resistance, increased tumor recurrence, and reduced survival of patients, making it an attractive target for cancer
treatment10. Survivin is highly expressed in breast cancer tumor compared with the normal breast tissue11.
Survivin participates in recurrence and progression of breast cancer, and is an important prognostic factor for
clinical outcome of breast cancer12. In this study, we investigated whether TP can induce apoptosis and its
downstream signaling pathway in human breast cancer cells, in order to clarify the mechanism by which TP
can exert inhibitory effect on breast cancer.
Results
Effect of TP on cell proliferation. Proliferation of SK-BR-3 and MCF-7 cells treated with TP was significantly
inhibited in a dose-dependent manner, compared to control cells (p , 0.0001, Figure 1).
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Effect of TP on cell morphology. Under an optical microscope
MCF-7 cells presented swollen, polygonal or round shapes, with
strong refraction and clear boundaries. MCF-7 cells treated by 5-
Fu (at concentration of 125 ug/ml) for 48 hours became round
and spindle, loosely distributed, with a few cells dissolved. MCF-7
cells treated by TP at concentration of 50 ug/ml for 48 hours became
spindle and round, loosely distributed, with a majority of cells
containing particles (Figure 2A).
Under electron microscope MCF-7 cells which were treated by 5-
Fu at concentration of 125 ug/ml for 48 hours showed enlarged cell
size, partial loss of villi and moderate degeneration. MCF-7 cells
treated by TP at a concentration of 50 ug/ml for 48 hours presented
changes in structure of the nucleus and organelles. We observed
apoptotic chromatin condensation and clumping, concentrated
cytoplasm, loose endoplasmic reticulum, as well as fusion of the
membrane and formation of bubbles (Figure 2B).
Apoptosis detected by Situ 3’-end labeling (TUNEL). Very few
apoptotic cells were observed in control and treated by 5-Fu (at a
concentration of 125 ug/ml) treated cells which were stained as a
light blue polygon. MCF-7 cells treated by TP (concentration of
50 ug/ml) for 48 hours showed increased apoptosis, which was
represented by a large amount of round or spindle-shaped cells,
with a majority of cells stained as brown (p , 0.05, Figure 3).
Survivin gene expression. Western blot showed that TP efficiently
inhibits survivin expression compared with control groups in breast
cancer cells SK-BR-3 and MCF-7 (p, 0.05, Figure 4). However, the
expression of PCNA, Cyclin D1, and Cyclin E was not significantly
downregulated by TP (Figure 5).
Effects of TP on cell growth of MCF-7 xenograft tumors in nude
mice. On days 10 and 17 after inoculation, the tumor volumes with
treatment of TP in the mice began to shrink. On days 24, 31 and 38
after treatment, the tumor volumes were significantly reduced (p ,
0.05).
Survivin protein expression in xenograft tumors in mice treated
with TP for 38 days was lower than that in control tumors (0.35 6
0.01 vs. 0.39 6 0.01, respectively; p , 0.05, Figure 6).
Discussion
In current study, we have demonstrated new molecular mechanism
of TP induced apoptosis in breast cancer cells. TP is able to induce
cell apoptosis by regulating a variety of signal transduction pathways
in breast cancer13. Our data may help to provide theoretical basis for
development of novel anticancer drugs.
TP fights against tumor by inhibiting cell proliferation, urokinase
activity, neovascularization, cancer metabolism, nitrification, as well
as inducing apoptosis of tumor cells14,15. Targeting molecules
involved in anti-apoptosis may provide new ideas in the aspect of
screening and development of antitumor drugs. TP regulates a vari-
ety of cellular signaling pathways to induce apoptosis of tumor cells.
TP inhibits the activity of protein kinase C and CDKs by producing
H2O2, upregulates the expression of IkBa, which is the inhibitor of
transcription factor activator NF-kb, and initiates caspases cascade
Figure 1 | Effects of TP on cell proliferation. Inhibition rate was dramatically increased as a dose-dependent manner in response to TP treatment in (A)
SK-BR-3 and (B) MCF-7 cells.
Figure 2 | Effect of TP on cell morphology. (A) Morphological changes of
MCF-7 cells after 5-Fu or TP treatment. (B) Ultramicrostructure changes
of MCF-7 cells induced by 5-Fu or TP.
Figure 3 | TUNEL staining of MCF-7 cells treated by 5-Fu or TP (*P ,
0.05).
www.nature.com/scientificreports
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in mitochondria16. Moreover, TP exerts its cancer chemoprevention
by blocking the mitogenic and differentiating signals throughmodu-
lating EGFR—MAPK signaling, as well as c-myc, c-jun and c-fos
expression17.
We observed decreased cell proliferation in response to TP in
breast cancer cells. Our data show that both 5-Fu and TP can inhibit
proliferation of MCF-7 and SK-BR-3 cells. 5-Fu is a widely used
antitumor drug. However, its toxicity may limit its efficacy in clinics.
To the contrary, TP has minimum side effect.
To elucidate the mechanism of TP against breast cancer, we
observed cellular ultrastructure, detected apoptotic cells, and mea-
sured the expression of anti-apoptotic gene survivin. Comprehensive
ultrastructure analysis demonstrated that 5-Fu treated cells experi-
enced necrosis, whereas TP treated cells experienced apoptosis.
Programmed cell necrosis occurs under either normal/physio-
logical or pathological conditions18. We observed TP-induced cell
death was significantly increased. Survivin, a new member of anti-
apoptotic protein (IAP) family, is the strongest inhibitor of apoptosis
that have ever been found. Survivin is overexpressed in breast cancer
and participates in the development and progression of breast cancer
by affecting cell proliferation and apoptosis19. We detected down-
regulation of survivin in MCF-7 cells treated by TP. The data indi-
cates that TP can efficiently induce apoptosis through inhibiting the
expression of survivin. Antioxidant potential of green tea derives
from its immunopotentiating properties. Its mode of action against
malignant behaviors of cancer cells demonstrates its potential as a
chemopreventive agent against breast cancer.
In summary, we have confirmed the anti-tumor activity of TP in
breast cancer cells and demonstrated one of the mechanisms by
which TP is able to induce apoptosis of breast cancer cells.
Methods
Cell lines, reagents, drugs and antibody.Human breast cancer cell line MCF-7 and
SK-BR-3 was a gift from Dr. Song at Department of Biomedical and Pharmaceutical
Sciences, College of Pharmacy, The University of Rhode Island, USA. Tea
Polyphenols was purchased from Sigma (USA). The 5-fluorourocil was purchased
from Shanghai Xudong Pharmaceutical. Thiazolyl blue tetrazolium bromide was
purchased from Fluka. Rabbit anti- human b-actin polyclonal antibody was
purchased from Boster (Wuhan, China). Rabbit anti-human Cyclin D1, Cyclin E,
PCNA and Survivin polyclonal antibody was purchased from Santa Cruz (USA).
Cell culture. MCF-7 and SK-BR-3cells were maintained in RPMI 1640 medium
supplemented with 10% fetal bovine serum, 50 U/ml penicillin and 50 mg/ml
streptomycin, and incubated at 37uC in a humidified atmosphere of 5% CO2.
MTT assay. Breast cancer MCF-7 and SK-BR-3 cells in logarithmic growth phase
were digested with trypsin, harvested, adjusted to a density of 2 3 104 cells/mL and
transferred to 96-well plates at a volume of 100 mL per well. After 24 h when cells
formed a monolayer, drugs at different concentrations were added to the medium.
After incubated for 24 h, MTT solution (5 mg/mL) was added (20 mL/well). Cells
were incubated at 37uC for another 4 h. Then the culture supernatant was removed
and DMSO was added (100 mL/well). Cells were incubated in a shaker at 37uC for
10 min until crystals were completely dissolved. The absorbance at 490 nm was
determined using a microplate reader. Each experiment was performed in
quintuplicate.
Electron microscopy. Breast cancer MCF-7 cells treated with TP were recovered
from cultures and fixed in 2% paraformaldehyde and 2.5% glutaraldehyde, and then
observed in a Zeiss transmission electron microscope.
TUNEL. The terminal deoxynucleotidyl transferase dUTP nick-end labeling
(TUNEL) method was used for detection of apoptotic cells, with an in situ cell death
detection assay (Roche Applied Science, Indianapolis, IN) according to the
manufacturer’s instructions. MCF-7 cells were incubated with drugs for 48 hours.
The number of positive cells in five randomly selected areas was counted under the
microscope (original magnification, 3200).
Western blot. Breast cancer cells MCF-7 and SK-BR-3 were digested with trypsin,
harvested, total protein concentration in each sample was determined using the
Bradford assay. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) was performed at a constant voltage of 100 V for 1 h. After electrophoresis,
proteins were electrically transferred onto a nitrocellulose membrane at a constant
voltage of 45 V for 1 h. After washing for three times (5minutes each) in TBST buffer
with shaking at room temperature, the membrane was incubated overnight with the
blocking solution (1% bovine serum albumin) at room temperature. The membrane
was then incubated with primary antibody (15500 dilution) for 2 h at room
temperature, followed by washing with TBST buffer three times (10 minutes each).
Figure 4 | Expression of Survivin in SK-BR-3 and MCF-7 cells after TP treatment (*P , 0.05). C: control; T: TP.
Figure 5 | Expression of PCNA, Cyclin D1, and Cyclin E in SK-BR-3 and
MCF-7 cells after TP treatment.
www.nature.com/scientificreports
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Subsequently, the membrane was incubated with alkaline phosphatase-labeled goat
anti-rabbit secondary antibody (15500) at room temperature for 1 h, followed by
washing with TBST for three times (10 minutes each) and TBS twice (10 minutes
each). BCIP/NBT substrate solution was used for color development to detect the
expression of survivin protein. Images were photographed using the Bio-Rad gel
imaging system (Bio-Rad, USA).
Nude mouse tumor xenograft model. Athymic BALB/c female nude mice (Chinese
National Academy of Sciences) were housed in laminar flow cabinets under specific
pathogen-free conditions and used at 6–8 weeks of age. All animal protocols were
approved by the Institutional Animal Care and Use Committee the Third Affiliated
Hospital of Harbin Medical University. MCF-7 breast cancer cells with the highest
Survivin expression were adjusted to a density of 2.53 107 cells/mL using serum-free
RPMI 1640 medium. Trypan blue staining indicated the ratio of viable cells was
.95%. Tumor cells (5 3 106 in 0.2 mL of HBSS) were suspended in serum free-
RPMI/Matrigel mixture (151 volume) and injected into the back of the nude mice by
using a 22-gauge needle. Strict aseptic technique was followed during the entire
process. The mean volume of the implanted tumors at the time of inoculation was
about 5 mm3, without differences among various groups. A total of 5 mice per group
were used. Three days after the injection and every fifth day thereafter, tumor volume
was recorded. The length and width of the tumors that developed were measured.
Three days after inoculation, TP (0.5%, 100 ul) were given every day. Mice were
sacrificed at 38 days. Tumor volume was calculated as (length/2) 3 (width2). Tumors
were harvested; half of each tumor was frozen in liquid nitrogen and stored at280uC;
half was fixed in 4% paraformaldehyde and stored at 70% ethanol. All procedures
were carried out according to the guidelines approved by the ethics committee at the
Third Affiliated Hospital of Harbin Medical University.
Statistical analysis. The ANOVA test was used to examine the differences in
numerical variables between the multiple groups. The statistical analyses were
conducted using the SPSS12.0 software. A p value of ,0.05 was considered
statistically significant.
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Figure 6 | Effects of TP on the growth of subcutaneous xenograft tumors derived from MCF-7 cells in nude mice (*P , 0.05). (A) Subcutaneous
xenograft tumor-bearing nude mice treated with TP for 38 days and tumor volumes at various time points after tumor implantation. (B) Expression of
survivin in MCF-7 cells treated with TP for 38 days.
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